Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
5,9 HKD | +3,51% | +11,11% | -29,93% |
Attività
Numero di dipendenti: 8 230
Vendite per attività
HKD in Milioni | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Orthopedics Devices
26,6
%
| 1 676 | 27,7 % | 1 751 | 26,6 % | +4,45% |
Cardiac Rhythm Management
24,3
%
| 1 713 | 28,3 % | 1 599 | 24,3 % | -6,65% |
Cardiovascular Devices
16,0
%
| 1 085 | 17,9 % | 1 050 | 16,0 % | -3,16% |
Endovascular and Peripheral Vascular Devices
15,8
%
| 824 | 13,6 % | 1 043 | 15,8 % | +26,54% |
Neurovascular Devices
9,5
%
| 459 | 7,6 % | 626 | 9,5 % | +36,31% |
Heart Valve
4,4
%
| 243 | 4,0 % | 288 | 4,4 % | +18,38% |
Others
2,5
%
| 12 | 0,2 % | 168 | 2,5 % | +1.246,81% |
Surgical Devices
0,5
%
| 37 | 0,6 % | 35 | 0,5 % | -3,86% |
Surgical Robot
0,4
%
| 3 | 0,0 % | 24 | 0,4 % | +846,79% |
Vendite per regione
HKD in Milioni | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
China
48,2
%
| 2 775 | 45,8 % | 3 176 | 48,2 % | +14,47% |
Europe
29,4
%
| 1 879 | 31,1 % | 1 933 | 29,4 % | +2,85% |
North America
11,5
%
| 738 | 12,2 % | 755 | 11,5 % | +2,31% |
Asia (excluding China)
7,6
%
| 500 | 8,3 % | 502 | 7,6 % | +0,33% |
Others
1,9
%
| 84 | 1,4 % | 123 | 1,9 % | +46,38% |
South America
1,4
%
| 75 | 1,2 % | 94 | 1,4 % | +25,33% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Zhao Hua Chang
CEO | Chief Executive Officer | 61 | 01/05/98 |
Hong Bin Sun
DFI | Director of Finance/CFO | 48 | 22/07/10 |
Glendy Wang
COO | Chief Operating Officer | 67 | 01/01/17 |
Bo Peng
BRD | Director/Board Member | 56 | 01/01/01 |
Qi Yi Luo
BRD | Director/Board Member | 62 | 01/01/03 |
Bruce Wang
PRN | Corporate Officer/Principal | - | 01/06/15 |
Wing Yan Yuen
SEC | Corporate Secretary | 53 | 15/01/20 |
Jonathan W. Chen
PRN | Corporate Officer/Principal | 49 | 01/07/12 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Norihiro Ashida
BRD | Director/Board Member | 70 | 01/11/06 |
Jonathan Chou
BRD | Director/Board Member | 60 | 03/09/10 |
Zhao Hua Chang
CEO | Chief Executive Officer | 61 | 01/05/98 |
Qi Yi Luo
BRD | Director/Board Member | 62 | 01/01/03 |
Director/Board Member | 80 | 01/11/06 | |
Hong Bin Sun
DFI | Director of Finance/CFO | 48 | 22/07/10 |
Guo En Liu
BRD | Director/Board Member | 67 | 03/09/10 |
Bo Peng
BRD | Director/Board Member | 56 | 01/01/01 |
Chun Yang Shao
BRD | Director/Board Member | 60 | 23/09/16 |
Wei Qin Sun
BRD | Director/Board Member | 44 | 30/08/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 1 834 477 000 | 924 603 678 ( 50,40 %) | 0 | 50,40 % |
Partecipazioni
Nome | Azioni | % | Valorizzazione |
---|---|---|---|
33 352 933 | 46.34% | 848 100 381 $ | |
153 940 915 | 44.36% | 553 787 048 $ | |
MICROPORT NEUROTECH LIMITED 53.35% | 310 871 340 | 53.35% | 332 859 270 $ |
Coordinate società
MicroPort Scientific Corp.
Zhangjiang Hi-Tech Park 1601 Zhangdong Road
201203, Shanghai
+86 21 3895 4600
http://www.microport.comSocietà del gruppo
Nome | Categoria e settore |
---|---|
Sorin CRM SAS
Sorin CRM SAS Medical SpecialtiesHealth Technology Sorin CRM SAS designs and manufactures implantable pacemakers and defibrillators. It offers ICDs, leads, holter equipment, and electrophysiology catheters. The company was founded on July 25, 1977 and is headquartered in Clamart, France. |
Medical Specialties
|
Settore
Vendite per attività
Vendite per regione
Revisioni EPS
Utili annuali - Indice di sorpresa
Variaz. 1 gen. | Capi. | |
---|---|---|
-29,93% | 1,38 Mrd | |
+8,07% | 219 Mrd | |
+6,59% | 183 Mrd | |
+11,26% | 133 Mrd | |
+26,57% | 108 Mrd | |
+0,65% | 63,06 Mrd | |
+13,35% | 52,02 Mrd | |
-0,62% | 48,2 Mrd | |
-0,93% | 40,37 Mrd | |
+11,54% | 39,35 Mrd |
- Borsa valori
- Azioni
- Azione 853
- Società MicroPort Scientific Corporation